MetaStat Inc. | |
Stock Exchange | Other OTC |
EPS |
$0.6 |
Market Cap |
$399.64 K |
Shares Outstanding |
5.88 M |
Public Float |
5.76 M |
Address |
27 Drydock Avenue Boston Massachusetts 02210 United States |
Employees | - |
Website | http://www.metastat.com |
Updated | 07/08/2019 |
MetaStat, Inc. engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes MetaSite Breast and MenaCalc platforms. The MetaSite Breast test measures the process of systemic metastasis and is intended for early stage breast cancer patients. |